PDCD1 and breast carcinoma: Sasidharan et al. also showed that both DNA and histone modifications are involved in the upregulation of PD-1, CTLA-4, TIM-3, and LAG3 in breast cancer, suggesting that these genes could be used as diagnostic/prognostic biomarkers and/or therapeutic targets as well [48].